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search, ;U1d it gets a higher score). The so ftware then ranks the 
results according to their fit to the query and presents the top 20 
matches. 
Aries Systems Corp. is offering photic aud tax assistance as 
standard; in addition, the package is supported by an Internet home 
page at http: //www.ariessys.com. The site offers useful information 
about the program, and there is a highly recornmended option of 
ordering a free demonstration version of the seHch engine. 
In conclusion, DermLiJ1e is an indispensable tool for a busy 
practitioner, a department, or research group. The package per-
Immunology of Human Melanoma: Tumor-Host Interac-
tion and Immunotberapy. Edited by Michele Maio, lOS Press, 
Amsterdam, 1996 (233 l'p., $95) 
Improved treatment options for advanced malignant melanoma 
are of g"eat significance for clinicians who participate ill the care of 
patients with this devastating disease . According to the American 
Cancer Society. about 38,300 new cases of melanoma will be 
diagnosed in the United States this year. Additionally, the rate of 
increase of melanoma is greater than that of any other Glncer except 
lung cancer among women. Early melanoma is treated successfully 
with surgery, but the course of advanced disease is rarely improved 
by the traditional adjuvant therapies of radiation and chemothenlpy. 
This lack of response to existing treatment options has fueled the 
efforts of basic researchers and clinicians to purslie other approaches 
for the treatment of melanoma. Immunotherapy h'15 received a 
tremendous amount of interest. Basic research in melanoma immu-
nology alld immunotherapy has expanded rapidly in the last several 
years with important advances in our understanding of the induc-
tion of host immune responses against this neoplasm . These 
findings arc in the early stages of translation into promising IlUman 
treatment protocols. 
This book, entitled "fmmullology of Human Melanoma: TUl11or-
Host Interaction and Iml1lunotherapy," edited by Michele Maio 
and published by lOS Press (Amsterdam), is an outstanding review 
of the ClIITent status of ollr understanding of immune mechanisms 
thar regulate melanoma progression and interaction with the host 
immune system. Importantly, the book also presents an up-to-date 
review of ongoing clinical iml11unotherapy trial s including some 
previously unpublished results. The book is divided into four 
sections that cover critical aspects of melanoma iml11unobiology 
that have shaped this t-ield in rccent years. 
The first three sections of the book provide an excellent SlIm-
mary of recent experimental trends in melanoma immunology. 
Section 1 describes tbe role of adhesion molecules and cytokines in 
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forms very well on a 4Hh-equipped PC with a double-speed 
CD-R.OM dnvc, altl~ough h:lV l11g to work With two C D's may b(1 
a minor drawback. rhe ~oftware IS ,upported for both PC j 
a,)o 
MAC. 
In spire or the tl or inconsiderable expen,e involved, I gn~atl,' 
recommend rhe usc of this p;lC kage . 
Daniel Milllouni, M. b . 
Ueilinson Medical Cellt ( 
Pctah-Tiqva, 49100 lsra:l 
thc local growth and. metastatic prof:res,ion of l1lelanoma cells i" 
11;110. The second sect,.on deal~ wIth. the role of HLA antigcns lind 
aCcessory 1110lec~les 111 • the II1ductlon of ~tfector cytotoxi c cell 
responses. The tblrd scct10n dlscusses the ra?ldl y expanding field t}( 
tumor antigen recogl1ltlOiI. Cbapter~ wllilln this section describ , 
new ly recognized melanoma-associated antigens and their anti: 
genic peptides, slIch as those coded by the MAGE family of genes 
and the tlll1ctional role . of these T cell-r~Slricted antigens in th~ 
development of Jlovel Innl1UJlotltcrapeutl c approaches for mel a~ 
l10ma patients. 
The final section describes ~ngoing.c!inical illlll1l1notherapy trials 
at sele cted research and e1mlcal facllttles both in Europe and th, 
United States. These clinical trials utili zing antiidiotypic antibodie s~ 
[lImor cell vaccines, peptide vaccines, 'lnd gent' transfer arc repre~ 
sentative of the type~ of clillical inllllunothcrapy efForts currently il'\ 
progress. This section, however, docs not provide a cOlllprehensiv\' 
view of clinical immunotherapy appmaches, bcc<luse all of the trials 
selected in this section ;lrc based OJ) active spt'c ific immunotherapy. 
FtII·thermore, as in any review of ollgoing research efforts, the 
stlldies of some well-k.nown investig<1tors are 11O( illcluded . Evell 
so, this section docs provide an excellcnl' overview of the types of 
clinical trials that cLirrently gencrate lhe promise of impro\'('d 
sLiccess in the treatment of human melanollla. 
The depth and range of lllelanonH' il1llnullology brought to-
gether by Michele Maio in thi s book will make it a valuable 
reference for both new 'l nd experienced in vestigators ill this field as 
well as those in other areas oftulllor biology. Addirioll;t1ly, the clear 
clini cal focus of the book will bendll clinici;)ns with all interest in 
the state of the art of experimental ill1nJullorherap), approaches tor 
the treatment of advanced IllChlllOl1la. 
Cheryl Armstrong. M .D. 
Atlanta, Georgia 
